The study of the role of hyperbaric oxygen therapy in the treatment of patients with inflammatory bowel disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200061193

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Age

14 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subjects hospitalized in the Department of Gastroenterology of Xiangya Hospital, diagnosed with inflammatory bowel disease (including Crohn's disease and ulcerative colitis); 2. aged over 14 years; 3. agreed to be enrolled and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to cooperate with completing treatment.

Design outcomes

Primary

Measure	Time frame
Crohn’s Disease Activity Index;	—

Countries

China

Contacts

Public ContactYu Peng

pengyu918@csu.edu.cn+86 13974899436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026